Astrana Health, Inc. Hits New 52-Week High of USD 41.23

Astrana Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 41.23 on June 23, 2026. This achievement underscores the company's strong performance in the miscellaneous industry, where it operates as a small-cap entity with a market capitalization of USD 1,362 million. Over the past year, Astrana Health has demonstrated a return of 4.62%, which, while below the S&P 500's performance of 22.24%, reflects the company's resilience in a competitive market. The stock's 52-week low was recorded at USD 18.08, highlighting the substantial growth it has achieved. Key financial metrics reveal a price-to-earnings (P/E) ratio of 58.00, indicating a premium valuation relative to earnings. The company maintains a debt-to-equity ratio of 0.79, suggesting a manageable level of debt. Additionally, Astrana Health boasts a return on equity of 3.02%, showcasing its efficiency in generating profits from shareholders' equity. With a robust annual growth rate of 35.87% in net sales and a remarkable 140.64% increase in net profit, Astrana Health's financial health appears strong, supported by high institutional holdings at 60.1%. This combination of factors positions the company favorably within its industry.